BBLG
Bone Biologics
$1.03
−$0.05 (−4.21%)Jul 27, 2026
Key metrics
The numbers that frame BBLG today
- Market cap
- $1.84M
- P/E (TTM)
- -0.6
- EV / FCF
- 1.0
- ROIC
- -10,769.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.01
- 52wk High
- $4.13
Growth
Revenue and earnings trend for BBLG
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BBLG
Is Bone Biologics a good buy?
No. Bone Biologics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case.
What is the market capitalization of BBLG?
Bone Biologics's market capitalization is $1.84M.
What is the P/E ratio for BBLG stock?
Bone Biologics's current P/E ratio is -0.6.
What is the 52-week high for BBLG stock?
The 52-week high for Bone Biologics is $4.13. The current close of $1.03 is 75.2% below that high.
What is the 52-week low for BBLG stock?
The 52-week low for Bone Biologics is $1.01. The current close of $1.03 is 1.5% above that low.
Does BBLG stock pay dividends?
Bone Biologics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BBLG?
Bone Biologics's Debt / Equity ratio is 0.